ID   Emma-spleen
AC   CVCL_5I29
SY   EmmaSpleen; EFS
DR   GEO; GSM1122237
DR   Kerafast; EMN011-FP
DR   Wikidata; Q54832288
RX   PubMed=24582862;
RX   PubMed=30601866;
CC   Doubling time: ~3 days (Kerafast=EMN011-FP).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_0C96 ! Emma-brain
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 12
//
RX   PubMed=24582862; DOI=10.1016/j.yexcr.2014.02.020;
RA   Kim J.-H., Frantz A.M., Anderson K.L., Graef A.J., Scott M.C.,
RA   Robinson S., Sharkey L.C., O'Brien T.D., Dickerson E.B.,
RA   Modiano J.F.;
RT   "Interleukin-8 promotes canine hemangiosarcoma growth by regulating
RT   the tumor microenvironment.";
RL   Exp. Cell Res. 323:155-164(2014).
//
RX   PubMed=30601866; DOI=10.1371/journal.pone.0210297;
RA   Dowling M., Samuelson J., Fadl-Alla B., Pondenis H.C., Byrum M.,
RA   Barger A.M., Fan T.M.;
RT   "Overexpression of prostate specific membrane antigen by canine
RT   hemangiosarcoma cells provides opportunity for the molecular detection
RT   of disease burdens within hemorrhagic body cavity effusions.";
RL   PLoS ONE 14:E0210297-E0210297(2019).
//